161 related articles for article (PubMed ID: 20107560)
1. New spectrophotometric and fluorimetric methods for determination of fluoxetine in pharmaceutical formulations.
Darwish IA; Amer SM; Abdine HH; Al-Rayes LI
Int J Anal Chem; 2009; 2009():257306. PubMed ID: 20107560
[TBL] [Abstract][Full Text] [Related]
2. Spectophotometric methods for determination of cefdinir in pharmaceutical formulations via derivatization with 1,2-naphthoquinone-4-sulfonate and 4-chloro-7-nitrobenzo-2-oxa-1, 3-diazole.
Gouda AA; Hashem H; Hassan W
Drug Test Anal; 2012 Dec; 4(12):991-1000. PubMed ID: 21538942
[TBL] [Abstract][Full Text] [Related]
3. Selective Spectrophotometric and Spectrofluorometric Methods for the Determination of Amantadine Hydrochloride in Capsules and Plasma via Derivatization with 1,2-Naphthoquinone-4-sulphonate.
Mahmoud AM; Khalil NY; Darwish IA; Aboul-Fadl T
Int J Anal Chem; 2009; 2009():810104. PubMed ID: 20140080
[TBL] [Abstract][Full Text] [Related]
4. Spectrophotometric and spectrofluorimetric determination of atomoxetine in pharmaceutical preparations.
Ulu ST
Pharmazie; 2011 Nov; 66(11):831-5. PubMed ID: 22204127
[TBL] [Abstract][Full Text] [Related]
5. Spectrofluorimetric determination of paroxetine HCl in pharmaceuticals via derivatization with 4-chloro-7- nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).
Walsh M; Belal F; El-Enany N; Elmansi H
J Fluoresc; 2011 Jan; 21(1):105-12. PubMed ID: 20593227
[TBL] [Abstract][Full Text] [Related]
6. Simple spectrophotometric method for determination of paroxetine in tablets using 1,2-naphthoquinone-4-sulphonate as a chromogenic reagent.
Darwish IA; Abdine HH; Amer SM; Al-Rayes LI
Int J Anal Chem; 2009; 2009():237601. PubMed ID: 20107559
[TBL] [Abstract][Full Text] [Related]
7. Novel spectrophotometric method for determination of cinacalcet hydrochloride in its tablets via derivatization with 1,2-naphthoquinone-4-sulphonate.
Darwish IA; Al-Shehri MM; El-Gendy MA
Chem Cent J; 2012 Feb; 6(1):11. PubMed ID: 22305461
[TBL] [Abstract][Full Text] [Related]
8. Validated spectrofluorimetric method for the determination of carbamazepine in pharmaceutical dosage forms after reaction with 4-chloro-7--nitrobenzo-2-oxa-1,3-diazole (NBD-Cl).
Walash MI; El-Enany N; Askar H
Luminescence; 2015 Nov; 30(7):1119-24. PubMed ID: 25783013
[TBL] [Abstract][Full Text] [Related]
9. Determination of lisinopril in dosage forms and spiked human plasma through derivatization with 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole (NBD-Cl) followed by spectrophotometry or HPLC with fluorimetric detection.
El-Emam AA; Hansen SH; Moustafa MA; El-Ashry SM; El-Sherbiny DT
J Pharm Biomed Anal; 2004 Jan; 34(1):35-44. PubMed ID: 14738917
[TBL] [Abstract][Full Text] [Related]
10. Fluorometric study for the reaction between sertraline and 7-chloro-4-nitrobenzo-2-oxa-1,3-diazole: kinetics, mechanism and application for the determination of sertraline in tablets.
Mahmoud AM; Darwish IA; Khalil NY
J Fluoresc; 2010 Mar; 20(2):607-13. PubMed ID: 20101448
[TBL] [Abstract][Full Text] [Related]
11. Novel spectrophotometric method for determination of some macrolide antibiotics in pharmaceutical formulations using 1,2-naphthoquinone-4-sulphonate.
Ashour S; Bayram R
Spectrochim Acta A Mol Biomol Spectrosc; 2012 Dec; 99():74-80. PubMed ID: 23041925
[TBL] [Abstract][Full Text] [Related]
12. Spectrofluorimetric and spectrophotometric determination of gliclazide in pharmaceuticals by derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.
El-Enany N
J AOAC Int; 2003; 86(2):209-14. PubMed ID: 12723907
[TBL] [Abstract][Full Text] [Related]
13. Development and validation of stability indicating method for determination of sertraline following ICH guidlines and its determination in pharmaceuticals and biological fluids.
Walash MI; Belal FF; El-Enany NM; Elmansi H
Chem Cent J; 2011 Oct; 5(1):61. PubMed ID: 21996025
[TBL] [Abstract][Full Text] [Related]
14. New spectrofluorimetric method with enhanced sensitivity for determination of paroxetine in dosage forms and plasma.
Darwish IA; Amer SM; Abdine HH; Al-Rayes LI
Anal Chem Insights; 2008 Nov; 3():145-55. PubMed ID: 19609398
[TBL] [Abstract][Full Text] [Related]
15. New spectrophotometric methods for the determination of moxifloxacin in pharmaceutical formulations.
Elbashir AA; Ebraheem SA; Elwagee AH; Aboul-Enein HY
Acta Chim Slov; 2013; 60(1):159-65. PubMed ID: 23841346
[TBL] [Abstract][Full Text] [Related]
16. Validated spectrophotometric methods for determination of Alendronate sodium in tablets through nucleophilic aromatic substitution reactions.
Walash MI; Metwally ME; Eid M; El-Shaheny RN
Chem Cent J; 2012 Apr; 6():25. PubMed ID: 22472190
[TBL] [Abstract][Full Text] [Related]
17. Determination of adamantane derivatives in pharmaceutical formulations by using spectrophotometric UV-Vis method.
Sobczak A; Muszalska I; Rohowska P; Inerowicz T; Dotka H; Jelińska A
Drug Dev Ind Pharm; 2013 May; 39(5):657-61. PubMed ID: 22568696
[TBL] [Abstract][Full Text] [Related]
18. Use of 7-fluoro-4-nitrobenzo-2-oxo-1,3-diazole (NBD-F) for the determination of ramipril in tablets and spiked human plasma.
Al-Majed AA; Al-Zehouri J
Farmaco; 2001 Apr; 56(4):291-6. PubMed ID: 11421257
[TBL] [Abstract][Full Text] [Related]
19. Spectrofluorimetric determination of fluvoxamine in dosage forms and plasma via derivatization with 4-chloro-7-nitrobenzo-2-oxa-1,3-diazole.
Darwish IA; Amer SM; Abdine HH; Al-Rayes LI
J Fluoresc; 2009 May; 19(3):463-71. PubMed ID: 18949539
[TBL] [Abstract][Full Text] [Related]
20. Validated spectroscopic methods for the estimation of triamterene in bulk powder and capsule form via derivatization reactions.
Ibrahim FA; Fouad MM; Rashed NS; Fathy ME; Mahmoud ES
Luminescence; 2018 Dec; 33(8):1423-1431. PubMed ID: 30362232
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
